Appeals court upholds ban on generic eye-pain drug from Apotex
The U.S. Court of Appeals for the Federal Circuit in Washington on Wednesday has agreed with a lower-court ruling that Apotex infringed on Allergan and Roche Palo Alto LLC's patent for Acular LS, a treatment for eye inflammation. The decision sustains a ban on the Canadian firm's generic version of the drug until next year.
Bloomberg | 07/09
This story published in FDLI SmartBrief on 07/10/2008
More from SmartBrief:
Appeals court overturns ruling on J&J patent for Ultracet
Thursday, August 27, 2009
Roche loses patent dispute with Amgen regarding anemia drug
Wednesday, September 16, 2009
Appeals court rules in favor of Cook Medical, Gore in patent suit
Friday, September 25, 2009
Get stories like these delivered daily for FREE:
|
FDLI SmartBrief
Designed specifically for professionals involved in the food and drug industry, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more |
|